SAN FRANCISCO, CA, Osanni Bio, a development-stage therapeutics platform reinventing discovery and development of new medicines, announced the close of a $190 million Series B financing. Read More
PALO ALTO, CA, Quantifind, the leader in AI-native Risk Intelligence for modern financial crime and national security operations, announced a $200 million growth investment led by Summit Partners. Read More
NEW YORK, NY, AI lab, General Intuition, closed a $320M Series A at $2.3B Series A in January 2026, just three months after a $133.7M seed round Read More
AUSTIN, TX, Ollin Biosciences, a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, announced an oversubscribed $330 million Series B financing. Read More